A 24-Year Analysis of Percutaneous Renal Biopsy Trends in Australia
The consensus supporting PRBs for SRMs is reflected in Australia. However, there remains significant heterogeneity between demographic groups. Further work is necessary to ensure standard-of-care treatment accessibility to prevent overtreatment.
Authors
- Marlon Perera
- Abdullah Al-Khanaty (ORCID: https://orcid.org/0000-0002-6234-3522)
- Declan G. Murphy (ORCID: https://orcid.org/0000-0002-7500-5899)
- Kieran Sandhu (ORCID: https://orcid.org/0009-0005-9659-2411)
- Nathan Lawrentschuk
- Jonathon Carll (ORCID: https://orcid.org/0000-0003-0948-6468)
Institutions
- Prostate Cancer Foundation of Australia (AU)
- The Royal Melbourne Hospital (AU)
- The University of Melbourne (AU)
- Peter MacCallum Cancer Centre (AU)
- Prostate Cancer Research (GB)
- Austin Health (AU)
Publication Details
- Journal
- Medical Sciences
- Published
- 2025-12-31
- DOI
- https://doi.org/10.3390/medsci14010019
- Citations
- 1
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52